English

FINCH THERAPEUTICS GROUP, INC.

EDGAR

FNCH Quarterly report (10-Q) · filed 2024-08-13

18 filing records in this dataset, filed from 2021-02-26 to 2024-08-13. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2024 Q2 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-4.73 million USD

2024 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -9088000 USD Source
Operating Cash Flow: -4362000 USD Source

Free cash flow

-4.73 million USD

2024 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -9088000 USD Source
Operating Cash Flow: -4362000 USD Source
Capital Expenditure: 0 USD Source
Capital Expenditure: 0 USD Source

Cash and cash equivalents: 16 million USD 2024-06-30 Source
Exact value

16035000 USD
Long-term debt including current maturities: 15 million USD 2022-12-31 Source
Exact value

15000000 USD
Shares outstanding: 1.61 million shares 2024-06-30 Source
Exact value

1605763 shares

Reported share-count change

0.06% · 1 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

1604761 shares · 2023-06-30· Source
1605763 shares · 2024-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

0 USD

2023-07-01 – 2024-06-30

Exact inputs and evidence

Revenue: 0 USD · 2023-07-01 – 2023-09-30 Source
Revenue: 107000 USD · 2023-01-01 – 2023-12-31 Source
Revenue: 107000 USD · 2023-01-01 – 2023-09-30 Source
Revenue: 0 USD · 2024-01-01 – 2024-03-31 Source
Revenue: 0 USD · 2024-04-01 – 2024-06-30 Source

Net income

-14.2 million USD

2023-07-01 – 2024-06-30

Exact inputs and evidence

Net income: -2416000 USD · 2023-07-01 – 2023-09-30 Source
Net income: -74754000 USD · 2023-01-01 – 2023-12-31 Source
Net income: -71713000 USD · 2023-01-01 – 2023-09-30 Source
Net income: -3876000 USD · 2024-01-01 – 2024-03-31 Source
Net income: -4834000 USD · 2024-04-01 – 2024-06-30 Source

Operating cash flow

-18.1 million USD

2023-07-01 – 2024-06-30

Exact inputs and evidence

Operating cash flow: -27799000 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -22538000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -31505000 USD · 2023-01-01 – 2023-12-31 Source
Operating cash flow: -27799000 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -4362000 USD · 2024-01-01 – 2024-03-31 Source
Operating cash flow: -9088000 USD · 2024-01-01 – 2024-06-30 Source
Operating cash flow: -4362000 USD · 2024-01-01 – 2024-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2024-08-13.

Financial data available through: 2023-12-31.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2023-12-31
Operating income: 4 of 11 periods available· newest 2023-12-31
Net income: 4 of 11 periods available· newest 2023-12-31
Operating cash flow: 4 of 11 periods available· newest 2023-12-31
Capital expenditure: 3 of 11 periods available· newest 2023-12-31
Total assets: 4 of 11 periods available· newest 2023-12-31
Total liabilities: 4 of 11 periods available· newest 2023-12-31
Current assets: 4 of 11 periods available· newest 2023-12-31
Current liabilities: 4 of 11 periods available· newest 2023-12-31
Cash and cash equivalents: 4 of 11 periods available· newest 2023-12-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2022-12-31
Shares outstanding: 4 of 11 periods available· newest 2023-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-87.6%

Prior period

USD 861,000

2022-01-01 – 2022-12-31
Current period

USD 107,000

2023-01-01 – 2023-12-31

Exact inputs and evidence

107000 − 861000 = -754000 USD

861000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
107000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · FINCH THERAPEUTICS GROUP, INC. · 2023-12-31 FINCH THERAPEUTICS GROUP, INC. (edgar:1733257) Year-over-year change in Revenue: -754000 USD Concept: fundies:Revenue Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733257?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 107000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733257/000095017024035952/fnch-20231231.htm#897131 Filing: 000095017024035952 Input fundies:Revenue: 861000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733257/000095017024035952/fnch-20231231.htm#898448 Filing: 000095017024035952
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 39.89 million

Prior period

−USD 114.65 million

2022-01-01 – 2022-12-31
Current period

−USD 74.75 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

-74754000 − -114646000 = 39892000 USD

-114646000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
-74754000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · FINCH THERAPEUTICS GROUP, INC. · 2023-12-31 FINCH THERAPEUTICS GROUP, INC. (edgar:1733257) Year-over-year change in Net income: 39892000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733257?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -74754000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733257/000095017024035952/fnch-20231231.htm#1740265 Filing: 000095017024035952 Input fundies:NetIncome: -114646000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733257/000095017024035952/fnch-20231231.htm#1741695 Filing: 000095017024035952
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 43.35 million

Prior period

−USD 74.85 million

2022-01-01 – 2022-12-31
Current period

−USD 31.51 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

-31505000 − -74851000 = 43346000 USD

-74851000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
-31505000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · FINCH THERAPEUTICS GROUP, INC. · 2023-12-31 FINCH THERAPEUTICS GROUP, INC. (edgar:1733257) Year-over-year change in Operating cash flow: 43346000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733257?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -31505000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733257/000095017024035952/fnch-20231231.htm#1088069 Filing: 000095017024035952 Input fundies:OperatingCashFlow: -74851000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733257/000095017024035952/fnch-20231231.htm#1089478 Filing: 000095017024035952
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-100%

Prior period

USD 2.18 million

2022-01-01 – 2022-12-31
Current period

USD 0

2023-01-01 – 2023-12-31

Exact inputs and evidence

0 − 2182000 = -2182000 USD

2182000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
0 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · FINCH THERAPEUTICS GROUP, INC. · 2023-12-31 FINCH THERAPEUTICS GROUP, INC. (edgar:1733257) Year-over-year change in Capital expenditure: -2182000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733257?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 0 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733257/000095017024035952/fnch-20231231.htm#1095858 Filing: 000095017024035952 Input fundies:CapitalExpenditure: 2182000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733257/000095017024035952/fnch-20231231.htm#1097245 Filing: 000095017024035952
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2023 2023-01-01 – 2023-12-31

Revenue USD 107,000 100% of revenue
Operating costs Derived USD 83.97 million 78,475% of revenue
Operating income −USD 83.86 million −78,375% of revenue
Tax, interest and other Derived −USD 9.11 million −8,511% of revenue
Net income −USD 74.75 million −69,864% of revenue

Cash

Operating cash flow −USD 31.51 million −29,444% of revenue
Capital expenditure USD 0 0% of revenue
Free cash flow Derived −USD 31.51 million −29,444% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2020 Operating loss: operating costs were 611% of revenue.
2021 Operating loss: operating costs were 424% of revenue.
2022 Operating loss: operating costs were 13,525% of revenue.
2023 Operating loss: operating costs were 78,475% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2020 2020-01-01 – 2020-12-31	7719000	47155000 Derived	-39436000	-95000 Derived	-39341000	Unavailable	Source 2020-01-01 – 2020-12-31: 7719000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -39436000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -39341000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -31329000 USD Inspect Operating Cash Flow Open source
2021 2021-01-01 – 2021-12-31	18532000	78517000 Derived	-59985000	-1825000 Derived	-58160000	-83116000 Derived	Source 2021-01-01 – 2021-12-31: 18532000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -59985000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -58160000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -67133000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 15983000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	861000	116454000 Derived	-115593000	-947000 Derived	-114646000	-77033000 Derived	Source 2022-01-01 – 2022-12-31: 861000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -115593000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -114646000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -74851000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 2182000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	107000	83968000 Derived	-83861000	-9107000 Derived	-74754000	-31505000 Derived	Source 2023-01-01 – 2023-12-31: 107000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -83861000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -74754000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -31505000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 0 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 107K 2023

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Revenue	7719000	Revenue: 7719000 Open source
20212021-12-31	Revenue	18532000	Revenue: 18532000 Open source
20222022-12-31	Revenue	861000	Revenue: 861000 Open source
20232023-12-31	Revenue	107000	Revenue: 107000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-87.6% 2023

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Year over year	No prior comparable period	Revenue: 7719000 Open source
20212021-12-31	Year over year	140.1%	Revenue: 18532000 Open source Revenue: 7719000 Open source
20222022-12-31	Year over year	-95.4%	Revenue: 861000 Open source Revenue: 18532000 Open source
20232023-12-31	Year over year	-87.6%	Revenue: 107000 Open source Revenue: 861000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -78,374.8% 2023

Net margin -69,863.6% 2023

Free cash flow margin -29,443.9% 2023

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Operating margin	-510.9%	Operating Income: -39436000 Open source Revenue: 7719000 Open source
20212021-12-31	Operating margin	-323.7%	Operating Income: -59985000 Open source Revenue: 18532000 Open source
20222022-12-31	Operating margin	-13,425.4%	Operating Income: -115593000 Open source Revenue: 861000 Open source
20232023-12-31	Operating margin	-78,374.8%	Operating Income: -83861000 Open source Revenue: 107000 Open source
20202020-12-31	Net margin	-509.7%	Net Income: -39341000 Open source Revenue: 7719000 Open source
20212021-12-31	Net margin	-313.8%	Net Income: -58160000 Open source Revenue: 18532000 Open source
20222022-12-31	Net margin	-13,315.4%	Net Income: -114646000 Open source Revenue: 861000 Open source
20232023-12-31	Net margin	-69,863.6%	Net Income: -74754000 Open source Revenue: 107000 Open source
20202020-12-31	Free cash flow margin	Not reported	Revenue: 7719000 Open source Operating Cash Flow: -31329000 Open source
20212021-12-31	Free cash flow margin	-448.5%	Revenue: 18532000 Open source Operating Cash Flow: -67133000 Open source Capital Expenditure: 15983000 Open source
20222022-12-31	Free cash flow margin	-8,946.9%	Revenue: 861000 Open source Operating Cash Flow: -74851000 Open source Capital Expenditure: 2182000 Open source
20232023-12-31	Free cash flow margin	-29,443.9%	Revenue: 107000 Open source Operating Cash Flow: -31505000 Open source Capital Expenditure: 0 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -31.5M 2023

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Operating cash flow	-31329000	Operating Cash Flow: -31329000 Open source
20212021-12-31	Operating cash flow	-67133000	Operating Cash Flow: -67133000 Open source
20222022-12-31	Operating cash flow	-74851000	Operating Cash Flow: -74851000 Open source
20232023-12-31	Operating cash flow	-31505000	Operating Cash Flow: -31505000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -31.5M 2023

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Free cash flow	Unavailable	Operating Cash Flow: -31329000 Open source
20212021-12-31	Free cash flow	-83116000	Operating Cash Flow: -67133000 Open source Capital Expenditure: 15983000 Open source
20222022-12-31	Free cash flow	-77033000	Operating Cash Flow: -74851000 Open source Capital Expenditure: 2182000 Open source
20232023-12-31	Free cash flow	-31505000	Operating Cash Flow: -31505000 Open source Capital Expenditure: 0 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

58.7% 2023

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Liabilities / assets	16.9%	Total Liabilities: 28002000 Open source Total Assets: 165338000 Open source
20212021-12-31	Liabilities / assets	10.3%	Total Liabilities: 23145000 Open source Total Assets: 225369000 Open source
20222022-12-31	Liabilities / assets	41.3%	Total Liabilities: 67228000 Open source Total Assets: 162939000 Open source
20232023-12-31	Liabilities / assets	58.7%	Total Liabilities: 32487000 Open source Total Assets: 55373000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

6.33× 2023

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Current assets / current liabilities	9.24×	Current Assets: 106164000 Open source Current Liabilities: 11486000 Open source
20212021-12-31	Current assets / current liabilities	9.64×	Current Assets: 142551000 Open source Current Liabilities: 14790000 Open source
20222022-12-31	Current assets / current liabilities	5.08×	Current Assets: 74551000 Open source Current Liabilities: 14689000 Open source
20232023-12-31	Current assets / current liabilities	6.33×	Current Assets: 25847000 Open source Current Liabilities: 4084000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2020 2020-01-01 – 2020-12-31	−USD 39.34 million Exact value Exact value: -39341000 USD 2020-01-01 – 2020-12-31: -39341000 USD Inspect Net Income Open source Share or cite Citation for Net Income · FINCH THERAPEUTICS GROUP, INC. · 2020-12-31 FINCH THERAPEUTICS GROUP, INC. (edgar:1733257) Net Income: -39341000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733257/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -39341000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733257/000095017022005243/fnch-20211231.htm#3556158 Filing: 000095017022005243 The citation records this snapshot. The page link may show a newer release later.	−USD 31.33 million Exact value Exact value: -31329000 USD 2020-01-01 – 2020-12-31: -31329000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · FINCH THERAPEUTICS GROUP, INC. · 2020-12-31 FINCH THERAPEUTICS GROUP, INC. (edgar:1733257) Operating Cash Flow: -31329000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733257/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -31329000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733257/000095017022005243/fnch-20211231.htm#2397954 Filing: 000095017022005243 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2021 2021-01-01 – 2021-12-31	−USD 58.16 million Exact value Exact value: -58160000 USD 2021-01-01 – 2021-12-31: -58160000 USD Inspect Net Income Open source Share or cite Citation for Net Income · FINCH THERAPEUTICS GROUP, INC. · 2021-12-31 FINCH THERAPEUTICS GROUP, INC. (edgar:1733257) Net Income: -58160000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733257/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -58160000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733257/000095017023009490/fnch-20221231.htm#3095828 Filing: 000095017023009490 The citation records this snapshot. The page link may show a newer release later.	−USD 67.13 million Exact value Exact value: -67133000 USD 2021-01-01 – 2021-12-31: -67133000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · FINCH THERAPEUTICS GROUP, INC. · 2021-12-31 FINCH THERAPEUTICS GROUP, INC. (edgar:1733257) Operating Cash Flow: -67133000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733257/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -67133000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733257/000095017023009490/fnch-20221231.htm#1853432 Filing: 000095017023009490 The citation records this snapshot. The page link may show a newer release later.	USD 15.98 million Exact value Exact value: 15983000 USD 2021-01-01 – 2021-12-31: 15983000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · FINCH THERAPEUTICS GROUP, INC. · 2021-12-31 FINCH THERAPEUTICS GROUP, INC. (edgar:1733257) Capital Expenditure: 15983000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733257/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 15983000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733257/000095017023009490/fnch-20221231.htm#1861389 Filing: 000095017023009490 The citation records this snapshot. The page link may show a newer release later.	−USD 83.12 million Calculation and evidence -67133000 − 15983000 USD Exact free cash flow: -83116000 USD 2021-01-01 – 2021-12-31: -67133000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 15983000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · FINCH THERAPEUTICS GROUP, INC. · 2021-12-31 FINCH THERAPEUTICS GROUP, INC. (edgar:1733257) Free cash flow: -83116000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733257?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -67133000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733257/000095017023009490/fnch-20221231.htm#1853432 Filing: 000095017023009490 Input fundies:CapitalExpenditure: 15983000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733257/000095017023009490/fnch-20221231.htm#1861389 Filing: 000095017023009490 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 114.65 million Exact value Exact value: -114646000 USD 2022-01-01 – 2022-12-31: -114646000 USD Inspect Net Income Open source Share or cite Citation for Net Income · FINCH THERAPEUTICS GROUP, INC. · 2022-12-31 FINCH THERAPEUTICS GROUP, INC. (edgar:1733257) Net Income: -114646000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733257/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -114646000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733257/000095017024035952/fnch-20231231.htm#1741695 Filing: 000095017024035952 The citation records this snapshot. The page link may show a newer release later.	−USD 74.85 million Exact value Exact value: -74851000 USD 2022-01-01 – 2022-12-31: -74851000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · FINCH THERAPEUTICS GROUP, INC. · 2022-12-31 FINCH THERAPEUTICS GROUP, INC. (edgar:1733257) Operating Cash Flow: -74851000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733257/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -74851000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733257/000095017024035952/fnch-20231231.htm#1089478 Filing: 000095017024035952 The citation records this snapshot. The page link may show a newer release later.	USD 2.18 million Exact value Exact value: 2182000 USD 2022-01-01 – 2022-12-31: 2182000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · FINCH THERAPEUTICS GROUP, INC. · 2022-12-31 FINCH THERAPEUTICS GROUP, INC. (edgar:1733257) Capital Expenditure: 2182000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733257/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2182000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733257/000095017024035952/fnch-20231231.htm#1097245 Filing: 000095017024035952 The citation records this snapshot. The page link may show a newer release later.	−USD 77.03 million Calculation and evidence -74851000 − 2182000 USD Exact free cash flow: -77033000 USD 2022-01-01 – 2022-12-31: -74851000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 2182000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · FINCH THERAPEUTICS GROUP, INC. · 2022-12-31 FINCH THERAPEUTICS GROUP, INC. (edgar:1733257) Free cash flow: -77033000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733257?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -74851000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733257/000095017024035952/fnch-20231231.htm#1089478 Filing: 000095017024035952 Input fundies:CapitalExpenditure: 2182000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733257/000095017024035952/fnch-20231231.htm#1097245 Filing: 000095017024035952 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 74.75 million Exact value Exact value: -74754000 USD 2023-01-01 – 2023-12-31: -74754000 USD Inspect Net Income Open source Share or cite Citation for Net Income · FINCH THERAPEUTICS GROUP, INC. · 2023-12-31 FINCH THERAPEUTICS GROUP, INC. (edgar:1733257) Net Income: -74754000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733257/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -74754000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733257/000095017024035952/fnch-20231231.htm#1740265 Filing: 000095017024035952 The citation records this snapshot. The page link may show a newer release later.	−USD 31.51 million Exact value Exact value: -31505000 USD 2023-01-01 – 2023-12-31: -31505000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · FINCH THERAPEUTICS GROUP, INC. · 2023-12-31 FINCH THERAPEUTICS GROUP, INC. (edgar:1733257) Operating Cash Flow: -31505000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733257/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -31505000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733257/000095017024035952/fnch-20231231.htm#1088069 Filing: 000095017024035952 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2023-01-01 – 2023-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · FINCH THERAPEUTICS GROUP, INC. · 2023-12-31 FINCH THERAPEUTICS GROUP, INC. (edgar:1733257) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733257/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733257/000095017024035952/fnch-20231231.htm#1095858 Filing: 000095017024035952 The citation records this snapshot. The page link may show a newer release later.	−USD 31.51 million Calculation and evidence -31505000 − 0 USD Exact free cash flow: -31505000 USD 2023-01-01 – 2023-12-31: -31505000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · FINCH THERAPEUTICS GROUP, INC. · 2023-12-31 FINCH THERAPEUTICS GROUP, INC. (edgar:1733257) Free cash flow: -31505000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1733257?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -31505000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733257/000095017024035952/fnch-20231231.htm#1088069 Filing: 000095017024035952 Input fundies:CapitalExpenditure: 0 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1733257/000095017024035952/fnch-20231231.htm#1095858 Filing: 000095017024035952 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

18 filings · 1,103 latest values · 1,103 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001733257, 1733257, FNCH, edgar:1733257

Also known as FINCH THERAPEUTICS GROUP, INC., Finch Therapeutics Group, Inc.

FINCH THERAPEUTICS GROUP, INC.

Latest quarter

Revenue

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2023 2023-01-01 – 2023-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation